Losartan and amlodipine on myocardial structure and function: A prospective, randomized, clinical trial

R. Fogari, A. Mugellini, M. Destro, L. Corradi, P. Lazzari, A. Zoppi, P. Preti, G. Derosa

Research output: Contribution to journalArticle

Abstract

Aims To compare the effects of losartan and amlodipine on myocardial structure and function in hypertensive patients with Type2 diabetes and left ventricular hypertrophy. Methods After a 4-week placebo period, patients were randomized to losartan 50mg (n=90) or amlodipine 5mg (n=91) for 12months, with a doubling of the dose in patients who did not respond after 4weeks. Blood pressure was measured in the clinic every month, while conventional echocardiography and acoustic densitometry (integrated backscatter analysis) were performed at the end of the placebo period and after 12months of treatment. Results Both drugs reduced systolic/diastolic blood pressure to a comparable extent. Losartan significantly reduced left ventricular mass index (-19%, P

Original languageEnglish
Pages (from-to)24-31
Number of pages8
JournalDiabetic Medicine
Volume29
Issue number1
DOIs
Publication statusPublished - Jan 2012

Keywords

  • Amlodipine
  • Hypertension
  • Losartan
  • Myocardial structure
  • Type2 diabetes mellitus

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Losartan and amlodipine on myocardial structure and function: A prospective, randomized, clinical trial'. Together they form a unique fingerprint.

  • Cite this